GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2511.00 25.15 (1.01%) | NSE 2516.20 32.20 (1.30%) | Trade | Add

BSE Live

Feb 09, 16:01

2511.00 25.15 (1.01%)

Volume

AVERAGE VOLUME

5-Day

2,328

10-Day

2,263

30-Day

2,865

6,012

Prev. Close

2485.85
Open Price

2409.25

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 09, 15:59

2516.20 32.20 (1.30%)

Volume

AVERAGE VOLUME

5-Day

65,478

10-Day

65,691

30-Day

80,992

104,890

Prev. Close

2484.00
Open Price

2489.00

Bid Price (Qty.)
2516.20 (787)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 15	Dec 13	Dec 12	Dec 11	Dec 10
	15 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	84.70	84.70	84.70	84.70	84.70
Total Share Capital	84.70	84.70	84.70	84.70	84.70
Reserves and Surplus	1,766.97	1,932.49	1,925.31	1,835.23	1,846.11
Total Reserves and Surplus	1,766.97	1,932.49	1,925.31	1,835.23	1,846.11
Total Shareholders Funds	1,851.67	2,017.19	2,010.02	1,919.93	1,930.81
NON-CURRENT LIABILITIES
Long Term Borrowings	2.63	3.61	4.14	4.59	5.16
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	8.74
Other Long Term Liabilities	5.29	4.97	4.97	5.00	0.00
Long Term Provisions	270.96	241.04	234.79	223.56	0.00
Total Non-Current Liabilities	278.87	249.61	243.90	233.15	13.90
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.00
Trade Payables	305.89	278.01	232.53	198.34	331.92
Other Current Liabilities	131.56	86.22	90.79	68.37	24.79
Short Term Provisions	668.42	518.83	512.43	591.28	490.05
Total Current Liabilities	1,105.86	883.07	835.75	857.98	846.76
Total Capital And Liabilities	3,236.40	3,149.87	3,089.67	3,011.07	2,791.47
ASSETS
NON-CURRENT ASSETS
Tangible Assets	123.06	100.07	89.40	99.13	108.93
Intangible Assets	0.00	0.00	0.00	0.00	0.00
Capital Work-In-Progress	115.22	61.86	43.79	16.19	8.72
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	238.28	161.93	133.19	115.32	117.65
Non-Current Investments	47.67	47.67	57.68	102.59	160.35
Deferred Tax Assets [Net]	82.91	92.11	86.54	61.47	65.14
Long Term Loans And Advances	288.31	232.87	189.69	152.93	0.00
Other Non-Current Assets	14.04	13.55	10.18	9.27	0.00
Total Non-Current Assets	671.22	548.14	477.27	441.58	343.14
CURRENT ASSETS
Current Investments	0.00	10.00	44.91	57.21	0.00
Inventories	368.86	342.40	282.04	330.14	281.54
Trade Receivables	100.32	96.39	115.90	85.31	47.03
Cash And Cash Equivalents	1,898.02	2,027.14	2,038.78	1,984.09	1,948.08
Short Term Loans And Advances	119.74	69.91	57.03	49.97	168.67
OtherCurrentAssets	78.25	55.89	73.74	62.76	3.02
Total Current Assets	2,565.18	2,601.73	2,612.40	2,569.48	2,448.33
Total Assets	3,236.40	3,149.87	3,089.67	3,011.07	2,791.47
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	489.32	464.54	355.91	376.52	275.18
CIF VALUE OF IMPORTS
Raw Materials	116.14	95.75	60.25	70.61	181.31
Stores, Spares And Loose Tools	301.39	204.56	142.34	108.87	0.00
Trade/Other Goods	301.39	204.56	142.34	108.87	0.00
Capital Goods	15.13	15.60	12.65	7.65	0.93
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	17.09	7.54	5.78	5.23	3.37
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	317.64	214.59	193.13	171.67	128.75
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	6.31	9.47	19.59	36.51	63.13
Other Earnings	63.61	53.08	51.92	43.37	44.86
BONUS DETAILS
Bonus Equity Share Capital	40.69	40.69	40.69	40.69	40.69
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	10.01	54.97	112.73
Non-Current Investments Unquoted Book Value	47.67	47.67	47.67	47.67	47.67
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	10.06	44.97	56.92	--
Current Investments Unquoted Book Value	--	--	--	--	--